Real-world outcomes following dose reduction of first-line ibrutinib in patients with WM Published 2024-01-18 Download video MP4 360p Download video MP4 720p Recommendations 04:02 Moving CAR-T therapy into earlier lines of treatment for myeloma and the need for effective bridging 03:45 Risk Factors for Disease Progression in Patients with Polycythemia Vera 02:06 Signs and Symptoms of a Brain Tumor | Dana-Farber Cancer Institute 03:38 Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Dr. Solomon explains 02:25 Bile Duct Cancer: A patient's journey 09:54 Are You Gaslighting Yourself? 4 Important Signs to Watch Out For 02:01 Best Doctor Characteristics, According to Dr. Frederick Mandell 04:06 CAR-T therapy in ALL: exploring dual-targeting of CD19 & CD22 to overcome resistance 03:40 What is Mosaicism? | Dana-Farber Cancer Institute 03:26 Understanding Low Grade Gliomas Video - Brigham and Women's Hospital 04:17 The evolving role of autoSCT in the age of CAR-T for multiple myeloma: current & future perspectives 11:39 Signs and Symptoms of Bladder Cancer 00:41 Neutrophil recovery phenotypes observed in patients following CD19 CAR T-cell therapy 04:56 All About Thalassaemia - Cartoon 02:25 How Important Are Diet and Exercise for Brain Tumor Patients? 02:41 Safety and efficacy of Actaly-cel™ in R/R pediatric B-ALL 04:32 Progeria clinical trial at Boston Children's Hospital 01:34 Updated BSH guidelines for managing DLBCL 04:57 Raynaud’s Phenomenon Video – Brigham and Women’s Hospital 03:41 What is triple-negative breast cancer? | Dana-Farber Cancer Institute Similar videos 1:26:57 Waldenstrom's macroglobulinaemia (WM) education webinar 03:24 Preventing ibrutinib flare in CLL 1:29:53 The Winning Way With BTK Inhibitors in CLL 04:09 What does the CLL forum data tell us? 35:31 CLL: BTK Inhibitors in Hematologic Oncology Pathways - Pathway-Guided Choices 1:16:16 Improving Patient Outcomes through Discovery: Waldenstrom’s Macroglobulinemia with Dr. Steve Treon 04:49 Case 1: Treatment Decision: Ibrutinib Monotherapy 1:01:01 Management of Waldenstrom Macroglobulinemia: an update 46:51 The Revolution In WM Treatment Whats On The Horizon 04:44 Customizing Care in CLL With BTK Inhibitors 51:47 ASCO Highlights Webinar Final v21Jul2021 59:17 Chronic Lymphocytic Leukemia (CLL) - diagnosis, prognosis and management with Ibrutinib 1:36:53 New Standards for CLL Care With BTK Inhibitors 1:14:36 Defying the Odds With Innovation in CLL 1:02:27 Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL 1:11:33 IWMF 2019 Ed Forum Live Stream - Dr. Steven Treon: Breaking News on WM 1:00:00 Novel BTK Inhibitors: Overcoming Intolerance, Resistance, and Other Challenges in B-Cell Cancers 50:30 Genomic Based Treatment Advances in WM 32:51 Part 2 - How do I use BTKi for CLL management? - Dr. Nitin Jain, USA More results